Ventas Inc (VTR) Stock

Ventas Inc trades at a P/E ratio of 145.26, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 129.87 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.74 indicates reasonable value when growth is considered.

With a beta of 0.80, Ventas Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.91 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Ventas Inc achieves a profit margin of 4.29%, meaning it retains $4.29 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 15.60% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 2.16% and ROA at 2.14%, the company achieves moderate returns on invested capital.

Ventas Inc's revenue grew by 21.80% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings increased by 201.60% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against REIT - HEALTHCARE FACILITIES industry averages for proper context.

Ventas Inc offers a dividend yield of 2.47%, paying $1.89 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment. To receive the next dividend, shares must be purchased before the ex-dividend date of Dec 31, 2025.

The dividend sustainability can be assessed through the payout ratio - Ventas Inc pays $1.89 per share in dividends against earnings of $0.53 per share, resulting in a payout ratio of 100.00%. This very high payout exceeding 90% raises sustainability concerns, as nearly all earnings go to dividends. Any earnings decline could force a dividend cut. The next dividend payment is scheduled for Jan 15, 2026.

Ventas Inc has a market capitalization of $36.2B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 469.73M shares outstanding, the company's ownership is relatively concentrated. As a participant in the REIT - HEALTHCARE FACILITIES industry, it competes with other firms in this sector.

Ventas Inc's book value per share is $26.33, while the current stock price is $75.34, resulting in a price-to-book (P/B) ratio of 2.86. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

21 analysts cover VTR with 81% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $85.65 implies 13.7% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:4 Strong Buy, 13 Buy, 4 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.